Michal Bassani-Sternberg

Michal Bassani-Sternberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michal Bassani-Sternberg sits on this spectrum.

Michal Bassani-Sternberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michal Bassani-Sternberg sits on this spectrum.

Best Publications

• Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

  Michal Bassani-Sternberg;Eva Bräunlein;Richard Klar;Thomas Engleitner;Thomas Engleitner

  720
  Citations

• Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation

  Michal Bassani-Sternberg;Sune Pletscher-Frankild;Lars Juhl Jensen;Matthias Mann

  539
  Citations

• Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.

  Chloe Chong;Chloe Chong;Markus Müller;HuiSong Pak;HuiSong Pak;Dermot Harnett

  330
  Citations

• Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.

  Michal Bassani-Sternberg;Chloé Chong;Chloé Chong;Philippe Guillaume;Philippe Guillaume;Marthe Solleder;Marthe Solleder

  285
  Citations

• Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes.

  Julien Racle;Justine Michaux;Georg Alexander Rockinger;Marion Arnaud

  283
  Citations

• Antitumour dendritic cell vaccination in a priming and boosting approach

  Alexandre Harari;Alexandre Harari;Michele Graciotti;Michele Graciotti;Michal Bassani-Sternberg;Michal Bassani-Sternberg;Lana E Kandalaft;Lana E Kandalaft

  252
  Citations

• Identification of tumor antigens with immunopeptidomics.

  Chloe Chong;Chloe Chong;George Coukos;George Coukos;Michal Bassani-Sternberg;Michal Bassani-Sternberg

  209
  Citations

• High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.

  Chloe Chong;Fabio Marino;Fabio Marino;HuiSong Pak;HuiSong Pak;Julien Racle;Julien Racle;Julien Racle

  206
  Citations

• The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands.

  David Gfeller;David Gfeller;Philippe Guillaume;Justine Michaux;Hui-Song Pak

  182
  Citations

• Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

  Unknown

  176
  Citations

• Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

  David Gfeller;Michal Bassani-Sternberg

  172
  Citations

• Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.

  Julien Schmidt;Angela R. Smith;Morgane Magnin;Julien Racle;Julien Racle

  168
  Citations

• Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

  Fabian Coscia;Fabian Coscia;Ernst Lengyel;Jaikumar Duraiswamy;Bradley Ashcroft

  164
  Citations

• Mass spectrometry-based antigen discovery for cancer immunotherapy

  Michal Bassani-Sternberg;George Coukos

  152
  Citations

• Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions.

  Michal Bassani-Sternberg;David Gfeller

  149
  Citations

• The SysteMHC Atlas project.

  Wenguang Shao;Patrick G.A. Pedrioli;Witold Wolski;Cristian Scurtescu

  148
  Citations

• Soluble plasma HLA peptidome as a potential source for cancer biomarkers

  Michal Bassani-Sternberg;Eilon Barnea;Ilan Beer;Irit Avivi

  147
  Citations

• Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

  Alice Newey;Beatrice Griffiths;Justine Michaux;Hui Song Pak

  135
  Citations

• Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.

  Marine Bruand;David Barras;David Barras;Marco Mina;Marco Mina;Eleonora Ghisoni

  132
  Citations

• Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes

  Unknown

  113
  Citations